Pro-angiogenic induction of myeloid cells for therapeutic angiogenesis can induce mitogen-activated protein kinase p38-dependent foam cell formation

BACKGROUND AIMS: Clinical trials for therapeutic angiogenesis use blood- or bone marrow-derived hematopoietic cells, endothelial progenitor cells (EPC) and mesenchymal stromal cells (MSC) for vascular regeneration. Recently concerns have emerged that all three cell types could also contribute to ath...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: ROHDE, EVA, SCHALLMOSER, KATHARINA, REINISCH, ANDREAS, HOFMANN, NICOLE A., PFEIFER, THOMAS, FRÖHLICH, ELEONORE, RECHBERGER, GERALD, LANZER, GERHARD, KRATKY, DAGMAR, STRUNK, DIRK
Formato: Artigo
Idioma:Inglês
Publicado em: 2010
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3173858/
https://ncbi.nlm.nih.gov/pubmed/21128706
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/14653249.2010.536214
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados